To elucidate whether the inhibitors were specific for SNAT1 or SNAT2, we measured the uptake of 100 μM radiolabelled proline in amino acid depleted SKOV3 ovarian cancer cells as an independent cellular model for inhibitor evaluation. The gene discussed is SLC38A2; the disease is ovarian cancer.